Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?
09:15am, Wednesday, 15'th Jan 2025
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t
TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst
11:38pm, Monday, 13'th Jan 2025
TG Therapeutics is already marketing an IV infusion of Briumvi, but is also developing a subcutaneous form, which could help it compete with other multiple sclerosis drugs. The company expects to repo
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
07:30am, Thursday, 09'th Jan 2025
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will present at the 43rd An
Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.
04:20pm, Tuesday, 03'rd Dec 2024
None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
TG Therapeutics to Participate in the Evercore HealthCONx Conference
08:00am, Friday, 29'th Nov 2024
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
06:00am, Thursday, 21'st Nov 2024
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing tec
Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.
02:47pm, Tuesday, 05'th Nov 2024
None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates
01:50pm, Tuesday, 05'th Nov 2024
TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million at the mid-point. The results were slightly underwhelming but generally in
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell
08:27pm, Monday, 04'th Nov 2024
TG Therapeutics' Q3 earnings missed EPS expectations, primarily due to higher non-cash compensation and increased R&D investments, despite Briumvi's revenue growth. Briumvi, a CD20-directed monoclonal
TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript
11:16am, Monday, 04'th Nov 2024
TG Therapeutics, Inc. (NASDAQ:TGTX ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Jenna Bosco - Senior Vice President of Corporate Communications Michael Weiss - C
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates
09:10am, Monday, 04'th Nov 2024
TG Therapeutics (TGTX) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.73 per share a year ago.
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics
09:00am, Monday, 04'th Nov 2024
Holly Springs, North Carolina site to provide security of supply for B-cell therapy for relapsing multiple sclerosis Holly Springs, North Carolina site to provide security of supply for B-cell therapy
AI Stocks Meta, Oracle Lead Five Names Near Buy Points
08:00am, Saturday, 02'nd Nov 2024
Two of the five top stocks to watch this week target the artificial intelligence market. The post AI Stocks Meta, Oracle Lead Five Names Near Buy Points appeared first on Investor's Business Daily.
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
08:06am, Friday, 01'st Nov 2024
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday November 4, 2024, at 8:30 AM ET to discuss results for the
Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.
08:00am, Friday, 11'th Oct 2024
None of our picks is Nvidia or Apple or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
